Celldex Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-36.5M |
| Depreciation & Amortization | $2.6M |
| Depreciation | — |
| Amortization | $949.0K |
| Stock-Based Compensation | $3.1M |
| Net Cash from Operating Activities | $-29.9M |
| Investing Activities | |
| Capital Expenditures | $528.0K |
| Business Acquisitions | — |
| Net Cash from Investing Activities | — |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | — |
| Net Change in Cash | — |
| Free Cash Flow | $-30.4M |